Denali Therapeutics Inc. ($DNLI)
Filing Information
| Accession Number | 0001724311-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 6, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
17,218
Total Value
$284,097.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
COFO and Secretary | Common Stock | โ | Jan 6, 2026 | Sale | 17,218 | $16.50 | $284,097.00 | 282,828 | Direct | โ | View Details |